Enzalutamide monotherapy: Extended follow-up of a phase II study in hormone-naive prostate cancer patients.

Bertrand Tombal, Michael Borre, Per Rathenborg, Patrick Werbrouck, Hendrik Van Poppel, Axel Heidenreich, Peter Iversen, Johan Braeckman, Jiri Heracek, Edwina Baskin-Bey, Taoufik Ouatas, Frank Perabo, De Phung, Matthew R. Smith

OriginalsprogEngelsk
TidsskriftJournal of Clinical Oncology
Vol/bind32
Udgave nummer4_suppl
Sider (fra-til)62
Antal sider1
ISSN0732-183X
StatusUdgivet - 2014

Citationsformater